264 related articles for article (PubMed ID: 35450214)
1. The Value of Dysregulated LncRNAs on Clinicopathology and Survival in Non-Small-Cell Lung
Wang J; Han X; Yuan Y; Gu H; Liao X; Jiang M
Front Genet; 2022; 13():821675. PubMed ID: 35450214
[No Abstract] [Full Text] [Related]
2. Increased expression of lncRNA ZEB1-AS1 in non-small cell lung cancer is associated with poor prognosis.
Xie J; Wu Y; Bian X; Chen D; Gui Q; Huang J
Int J Clin Exp Pathol; 2018; 11(7):3703-3707. PubMed ID: 31949753
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of NM23 expression in patients with non-small cell lung cancer: A systematic review and meta-analysis.
Min SH; Zheng QQ
Medicine (Baltimore); 2021 Nov; 100(47):e27919. PubMed ID: 34964763
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNAs as potential biomarkers and therapeutic targets in gallbladder cancer: a systematic review and meta-analysis.
Zhong Y; Wu X; Li Q; Ge X; Wang F; Wu P; Deng X; Miao L
Cancer Cell Int; 2019; 19():169. PubMed ID: 31297033
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis.
Zhang G; Cai J
J BUON; 2019; 24(6):2553-2559. PubMed ID: 31983132
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
7. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNAs function as novel predictors and targets of non-small cell lung cancer: a systematic review and meta-analysis.
Xiong Y; Wang T; Wang M; Zhao J; Li X; Zhang Z; Zhou Y; Liu J; Jia L; Han Y
Oncotarget; 2018 Feb; 9(13):11377-11386. PubMed ID: 29541420
[TBL] [Abstract][Full Text] [Related]
9. The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysis.
Tian T; Wang M; Lin S; Guo Y; Dai Z; Liu K; Yang P; Dai C; Zhu Y; Zheng Y; Xu P; Zhu W; Dai Z
Mol Ther Nucleic Acids; 2018 Sep; 12():359-369. PubMed ID: 30195774
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of long non coding RNAs in non small cell lung cancer: A meta-analysis.
Wang M; Ma X; Zhu C; Guo L; Li Q; Liu M; Zhang J
Oncotarget; 2016 Dec; 7(49):81292-81304. PubMed ID: 27833074
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Role of EGFR/p-EGFR in Patients With Nasopharyngeal Carcinoma: A Meta-Analysis.
Chen X; Liang R; Lai L; Chen K; Zhu X
Front Oncol; 2021; 11():697369. PubMed ID: 34490092
[TBL] [Abstract][Full Text] [Related]
12. The impact of LncRNA dysregulation on clinicopathology and survival of pancreatic cancer: a systematic review and meta-analysis (PRISMA compliant).
Seyed Hosseini E; Nikkhah A; Sotudeh A; Alizadeh Zarei M; Izadpanah F; Nikzad H; Haddad Kashani H
Cancer Cell Int; 2021 Aug; 21(1):447. PubMed ID: 34425840
[TBL] [Abstract][Full Text] [Related]
13. lncRNAs as potential molecular biomarkers for the clinicopathology and prognosis of glioma: A systematic review and meta-analysis.
Zhou Q; Liu J; Quan J; Liu W; Tan H; Li W
Gene; 2018 Aug; 668():77-86. PubMed ID: 29777909
[TBL] [Abstract][Full Text] [Related]
14. Abnormally expressed lncRNAs in the prognosis and clinicopathology of oesophageal cancer: a systematic review and meta-analysis.
Qian P; Xu Z; Chen H; Yue S; Lv Y
J Genet; 2020; 99():. PubMed ID: 32529986
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Significance and Prognostic Value of ALDH1 Expression in Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis.
Li D; Cao Y; Luo CW; Zhang LP; Zou YB
Recent Pat Anticancer Drug Discov; 2023 Oct; ():. PubMed ID: 37818578
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of long noncoding RNAs in non-small cell lung cancer: a meta-analysis.
Jing W; Li N; Wang Y; Liu X; Liao S; Chai H; Tu J
Oncotarget; 2017 Jan; 8(3):3957-3968. PubMed ID: 27992369
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinicopathological significance of downregulated E-cadherin expression in patients with non-small cell lung cancer (NSCLC): a meta-analysis.
Yang YL; Chen MW; Xian L
PLoS One; 2014; 9(6):e99763. PubMed ID: 24978478
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases.
Ye Z; Zhang X; Luo Y; Li S; Huang L; Li Z; Li P; Chen G
PLoS One; 2016; 11(9):e0163162. PubMed ID: 27657690
[TBL] [Abstract][Full Text] [Related]
20. Association Between Efficacy of Immune Checkpoint Inhibitors and Sex: An Updated Meta-Analysis on 21 Trials and 12,675 Non-Small Cell Lung Cancer Patients.
Xue C; Zheng S; Dong H; Lu X; Zhang X; Zhang J; Li J; Cui H
Front Oncol; 2021; 11():627016. PubMed ID: 34513654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]